Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Amortizatization of Intangibles (2016 - 2021)

Historic Amortizatization of Intangibles for BioRestorative Therapies (BRTX) over the last 11 years, with Q4 2021 value amounting to $65041.0.

  • BioRestorative Therapies' Amortizatization of Intangibles changed N/A to $65041.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year decrease of 7857.1%. This contributed to the annual value of $1.1 million for FY2021, which is 5967.45% down from last year.
  • Latest data reveals that BioRestorative Therapies reported Amortizatization of Intangibles of $65041.0 as of Q4 2021.
  • In the past 5 years, BioRestorative Therapies' Amortizatization of Intangibles ranged from a high of $2.8 million in Q1 2020 and a low of $65041.0 during Q4 2021
  • Its 5-year average for Amortizatization of Intangibles is $629704.6, with a median of $365719.5 in 2018.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first surged by 118551.81% in 2018, then plummeted by 8515.96% in 2021.
  • BioRestorative Therapies' Amortizatization of Intangibles (Quarter) stood at $242380.0 in 2017, then surged by 67.29% to $405475.0 in 2018, then soared by 266.85% to $1.5 million in 2019, then skyrocketed by 88.97% to $2.8 million in 2020, then crashed by 97.69% to $65041.0 in 2021.
  • Its last three reported values are $65041.0 in Q4 2021, $325964.0 for Q3 2021, and $325374.0 during Q2 2021.